Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Conditions:   Soft Tissue Sarcoma Adult;   Advanced Cancer Interventions:   Drug: Association of Nivolumab + Relatlimab;   Drug: Nivolumab Sponsors:   Institut Bergonié;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials